Toxicity and in vivo biological effect of the nanoparticular self-supported hydrogel of a thermosensitive copolymer for non-invasive drug delivery
Weiwei Wang
Department of polymer science and engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300072, China
Search for more papers by this authorLiandong Deng
Department of polymer science and engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300072, China
Search for more papers by this authorPingsheng Huang
Department of polymer science and engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300072, China
Search for more papers by this authorShuxin Xu
Department of polymer science and engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300072, China
Search for more papers by this authorXu Li
Tianjin Institute of Medical and Pharmaceutical Science, Tianjin, 300020, China
Search for more papers by this authorNan Lv
Tianjin Institute of Medical and Pharmaceutical Science, Tianjin, 300020, China
Search for more papers by this authorLei Wang
Tianjin Institute of Medical and Pharmaceutical Science, Tianjin, 300020, China
Search for more papers by this authorRenjie Hu
Tianjin Institute of Medical and Pharmaceutical Science, Tianjin, 300020, China
Search for more papers by this authorJianhua Zhang
Department of polymer science and engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300072, China
Search for more papers by this authorCorresponding Author
Anjie Dong
Department of polymer science and engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300072, China
Key Laboratory of Systems Bioengineering, Ministry of Education of China, Tianjin 300072, China
Correspondence to: A. Dong; e-mail: [email protected]Search for more papers by this authorWeiwei Wang
Department of polymer science and engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300072, China
Search for more papers by this authorLiandong Deng
Department of polymer science and engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300072, China
Search for more papers by this authorPingsheng Huang
Department of polymer science and engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300072, China
Search for more papers by this authorShuxin Xu
Department of polymer science and engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300072, China
Search for more papers by this authorXu Li
Tianjin Institute of Medical and Pharmaceutical Science, Tianjin, 300020, China
Search for more papers by this authorNan Lv
Tianjin Institute of Medical and Pharmaceutical Science, Tianjin, 300020, China
Search for more papers by this authorLei Wang
Tianjin Institute of Medical and Pharmaceutical Science, Tianjin, 300020, China
Search for more papers by this authorRenjie Hu
Tianjin Institute of Medical and Pharmaceutical Science, Tianjin, 300020, China
Search for more papers by this authorJianhua Zhang
Department of polymer science and engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300072, China
Search for more papers by this authorCorresponding Author
Anjie Dong
Department of polymer science and engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300072, China
Key Laboratory of Systems Bioengineering, Ministry of Education of China, Tianjin 300072, China
Correspondence to: A. Dong; e-mail: [email protected]Search for more papers by this authorAbstract
Injectable thermosensitive hydrogels provide local non-invasive platforms for sustained drug release,tissue engineering and cellular immunity. As a long-term implant, the toxicity and in vivo biological effect should be concerned.Previously we developed a novel type of injectable nanoparticular self-supported hydrogel (PECT NPsGel)of PEG and pendent cycle ethers modified poly(ε-caprolactone) triblock copolymer (PECT), which could sustainedly release PECT or drug-loaded PECT nanoparticles with the hydrogel disassembly and provided efficient antitumor activity and significant decrease of side effects. Herein, the aim of this work was to reveal the toxicity and in vivo biological effect of PECT nanoparticles and PECT NPsGel. In vitro cytotoxicity indicated no cell cytotoxicity was observed when the concentration of PECT nanoparticle was up to 500 µg/mL, and also nomutagenic effect and no genotoxicity were observed.In vivo intravenous injection of PECT nanoparticles demonstrated that the LD50 was approximate high to 2.564 g/kg, and compared with the control mice, the mice treated with daily administration of PECT nanoparticles showed no difference in the physical or behavioral alterations, body weight changes, biochemical and hematological parameters as well as organ coefficients. The in vivo chronic effect of PECT NPsGelconfirmed no toxic lesions to animals in a whole period of three months even the dosage was high to 20 g/kg. These findings indicated PECT nanoparticles and PECT NPsGel were of well biocompatibility and did not provoke any side effect to body, which represented a new class of injectable and non-invasive systemic or site-specific delivery carrier. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 17–29, 2014.
Supporting Information
Additional Supporting Information may be found in the online version of this article.
Filename | Description |
---|---|
jbma34694-sup-0001-suppinfo.doc9.2 MB | Supporting Information |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics: An emerging treatment modality for cancer. Nat Rev Drug Discov 2008; 7: 771–782.
- 2Wang Y-C, Tang L-Y, Li Y, Wang J. Thermoresponsive block copolymers of poly(ethylene glycol) and polyphosphoester: Thermo-induced self-assembly, biocompatibility, and hydrolytic degradation. Biomacromolecules 2009; 10: 66–73.
- 3Gou M, Zheng X. Poly(ε-caprolactone)/poly(ethylene glycol)/poly(ε-caprolactone) nanoparticles: Preparation, characterization, and application in doxorubicin delivery. J Phys Chem B 2009; 113: 12928–12933.
- 4Weiss B, Schaefer UF, Zapp J, Lamprecht A, Stallmach A, Lehr C-M. Nanoparticles made of fluorescence-labelled poly(L-lactide-co-glycolide): Preparation, stability, and biocompatibility. J Nanosci Nanotechnol 2006; 6: 3048–3056.
- 5Yu L, Zhang Z, Zhang H, Ding J. Biodegradability and biocompatibility of thermoreversible hydrogels formed from mixing a sol and a precipitate of block copolymers in water. Biomacromolecules 2010; 11: 2169–2178.
- 6Moon HJ, Ko DY, Park MH, Joo MK, Jeong B. Temperature-responsive compounds as in situ gelling biomedical materials. Chem Soc Rev 2012; 41: 4860–4883.
- 7Li YL, Rodrigues J, Tomas H. Injectable and biodegradable hydrogels: Gelation, biodegradation and biomedical applications. Chem Soc Rev 2012; 41: 2193–2221.
- 8Kempe S, Mäder K. In situ forming implants—An attractive formulation principle for parenteral depot formulations. J Controlled Release 2012; 161: 668–679.
- 9Kang YM, Kim GH, Kim JI, Kim DY, Lee BN, Yoon SM, Kim JH, Kim MS. In vivo efficacy of an intratumorally injected in situ-forming doxorubicin/poly(ethylene glycol)-b-polycaprolactone diblock copolymer. Biomaterials 2011; 32: 4556–4564.
- 10Zhang Z, Ni J, Chen L, Yu L, Xu J, Ding J. Biodegradable and thermoreversible PCLA-PEG-PCLA hydrogel as a barrier for prevention of post-operative adhesion. Biomaterials 2011; 32: 4725–4736.
- 11Fu SZ, Ni PY, Wang BY, Chu BY, Zheng L, Luo F, Luo JC, Qian ZY. Injectable and thermo-sensitive PEG-PCL-PEG copolymer/collagen/n-HA hydrogel composite for guided bone regeneration. Biomaterials 2012; 33: 4801–4809.
- 12Yu L, Ding J, Injectable hydrogels as unique biomedical materials. Chem Soc Rev 2008; 37: 1473–1481
- 13Zhang Z, Ni J, Chen L, Yu L, Xu J, Ding J. 2012. Encapsulation of cell-adhesive RGD peptides into a polymeric physical hydrogel to prevent postoperative tissue adhesion. J Biomed Mater Res Part B 2012; 100B: 1599–1609.
- 14Hubbell JA, Chilkoti A. Nanomaterials for drug delivery. Science 2012; 337: 303–305.
- 15Loverde SM, Klein ML, Discher DE. Nanoparticle shape improves delivery: Rational coarse grain molecular dynamics (rCG-MD) of Taxol in worm-like PEG-PCL micelles. Adv Mater 2012; 24: 3823–3830.
- 16Lee ALZ, Venkataraman S, Sirat SBM, Gao S, Hedrick JL, Yang YY. The use of cholesterol-containing biodegradable block copolymers to exploit hydrophobic interactions for the delivery of anticancer drugs. Biomaterials 2012; 33: 1921–1928.
- 17Chiu Y-L, Chen S-C, Su C-J, Hsiao C-W, Chen Y-M, Chen H-L, Sung H-W. pH-triggered injectable hydrogels prepared from aqueous N-palmitoyl chitosan: In vitro characteristics and in vivo biocompatibility. Biomaterials 2009; 30: 4877–4888.
- 18Kang YM, Lee SH, Lee JY, Son JS, Kim BS, Lee B, Chun HJ, Min BH, Kim JH, Kim MS. A biodegradable, injectable, gel system based on MPEG-b-(PCL-ran-PLLA) diblock copolymers with an adjustable therapeutic window. Biomaterials 2010; 31: 2453–2460.
- 19Al-Abd AM, Hong KY, Song SC, Kuh HJ. Pharmacokinetics of doxorubicin after intratumoral injection using a thermosensitive hydrogel in tumor-bearing mice. J Controlled Release 2010; 142: 101–107.
- 20Yi H, Cho H-J, Cho S-M, Lee D-G, El-Aty AA, Yoon S-J, Bae G-W, Nho K, Kim B, Lee C-H. Pharmacokinetic properties and antitumor efficacy of the 5-fluorouracil loaded PEG-hydrogel. BMC Cancer 2010; 10: 211–218.
- 21Sutton D, Nasongkla N, Blanco E, Gao J. Functionalized micellar systems for cancer targeted drug delivery. Pharm Res 2007; 24: 1029–1046.
- 22Homsi J, Simon GR, Garrett CR, Springett G, De Conti R, Chiappori A, Munster PN, Burton MK, Stromatt S, Allievi C, Angiuli P, Eisenfeld A, Sullivan DM, Daud AI. Phase I trial of poly-L-glutamate camptothecin (CT-2106) administered weekly in patients with advanced solid malignancies. Clin Cancer Res 2007; 13: 5855–5861.
- 23Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 2006; 6: 688–701.
- 24Aaron DuVall G, Tarabar D, Seidel RH, Elstad NL, Fowers KD. Phase 2: A dose-escalation study of OncoGel (ReGel/paclitaxel), a controlled-release formulation of paclitaxel, as adjunctive local therapy to external-beam radiation in patients with inoperable esophageal cancer. Anticancer Drugs 2009; 20: 89–95.
- 25Vukelja SJ, Anthony SP, Arseneau JC, Berman BS, Casey Cunningham C, Nemunaitis JJ, Samlowski WE, Fowers KD. Phase 1 study of escalating-dose OncoGel(R) (ReGel(R)/paclitaxel) depot injection, a controlled-release formulation of paclitaxel, for local management of superficial solid tumor lesions. Anti-Cancer Drugs 2007; 18: 283–289.
- 26Lewinski N, Colvin V, Drezek R. Cytotoxicity of nanoparticles. Small 2008; 4: 26–49.
- 27Tang F, Li L, Chen D. Mesoporous silica nanoparticles: Synthesis, biocompatibility and drug delivery. Adv Mater 2012; 24: 1504–1534.
- 28Chawla K, Yu T-B, Liao SW, Guan Z. Biodegradable and biocompatible synthetic saccharide-peptide hydrogels for three-dimensional stem cell culture. Biomacromolecules 2011; 12: 560–567.
- 29Dankers PYW, van Luyn MJA, Huizinga-van der Vlag A, van Gemert GML, Petersen AH, Meijer EW, Janssen HM, Bosman AW, Popa ER. Development and in-vivo characterization of supramolecular hydrogels for intrarenal drug delivery. Biomaterials 2012; 33: 5144–5155.
- 30Lanao RPF, Leeuwenburgh SCG, Wolke JGC, Jansen JA. Bone response to fast-degrading, injectable calcium phosphate cements containing PLGA microparticles. Biomaterials 2011; 32: 8839–8847.
- 31Shachaf Y, Gonen-Wadmany M, Seliktar D. The biocompatibility of Pluronic (R) F127 fibrinogen-based hydrogels. Biomaterials 2010; 31: 2836–2847.
- 32Henderson E, Lee BH, Cui Z, McLemore R, Brandon TA, Vernon BL. In vivo evaluation of injectable thermosensitive polymer with time-dependent LCST. J Biomed Mater Res A 2009; 90A: 1186–1197.
- 33Salgado CL, Sanchez EMS, Zavaglia CAC, Granja PL. Biocompatibility and biodegradation of polycaprolactone-sebacic acid blended gels. J Biomed Mater Res A 2012; 100A: 243–251.
- 34Biazar E, Roveimiab Z, Shahhosseini G, Khataminezhad M, Zafari M, Majdi A. Biocompatibility evaluation of a new hydrogel dressing based on polyvinylpyrrolidone/polyethylene glycol. J Biomed Biotechnol 2012; 2012: 343989; doi:10.1155/2012/343989.
- 35Bae YH, Park K. Targeted drug delivery to tumors: Myths, reality and possibility. J Controlled Release 2011; 153: 198–205.
- 36Yan J, Yang L, Wang G, Xiao Y, Zhang B, Qi N. Biocompatibility evaluation of chitosan-based injectable hydrogels for the culturing mice mesenchymal stem cells in vitro. J Biomater Appl 2010; 24: 625–637.
- 37Azab AK, Doviner V, Orkin B, Kleinstem J, Srebnik M, Nissan A, Rubinstein A. Biocompatibility evaluation of crosslinked chitosan hydrogels after subcutaneous and intraperitoneal implantation in the rat. J Biomed Mater Res A 2007; 83A: 414–422.
- 38Cui Z, Lee BH, Pauken C, Vernon BL. Degradation, cytotoxicity, and biocompatibility of NIPAAm-based thermosensitive, injectable, and bioresorbable polymer hydrogels. J Biomed Mater Res A 2011; 98A: 159–166.
- 39Sharifi S, Imani M, Mirzadeh H, Atai M, Ziaee F, Bakhshi R. Synthesis, characterization, and biocompatibility of novel injectable, biodegradable, and in situ crosslinkable polycarbonate-based macromers. J Biomed Mater Res A 2009; 90A: 830–843.
- 40Hernandez L, Parra J, Vazquez B, Lopez Bravo A, Collia F, Goni I, Gurruchaga M, San Roman J. Injectable acrylic bone cements for vertebroplasty based on a radiopaque hydroxyapatite. Bioactivity and biocompatibility. J Biomed Mater Res B Appl Biomater 2009; 88B: 103–114.
- 41Laschke MW, Witt K, Pohlemann T, Menger MD. Injectable nanocrystalline hydroxyapatite paste for bone substitution: In vivo analysis of biocompatibility and vascularization. J Biomed Mater Res B 2007; 82B: 494–505.
- 42Wang W, Deng L, Liu S, Li X, Zhao X, Hu R, Zhang J, Han H, Dong A. Adjustable degradation and drug release of a thermosensitive hydrogel based on a pendant cyclic ether modified poly(epsilon-caprolactone) and poly(ethylene glycol)co-polymer. Acta Biomater 2012; 8: 3963–3973.
- 43Wang W, Chang L, Li X, Wu Y, Xing J, Deng L, Dong A. Controlled thermal gelation of poly(epsilon-caprolactone)/poly(ethylene glycol) block copolymers by modifying cyclic ether pendant groups on poly(epsilon-caprolactone). Soft Matter 2012; 8: 1575–1583.
- 44Yin L, Zhao X, Cui L, Ding J, He M, Tang C, Yin C. Cytotoxicity and genotoxicity of superporous hydrogel containing interpenetrating polymer networks. Food Chem Toxicol 2009; 47: 1139–1145.
- 45Huang Y, Gao H, Gou M, Ye H, Liu Y, Gao Y, Peng F, Qian Z, Cen X, Zhao Y. Acute toxicity and genotoxicity studies on poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanomaterials. Mutat Res-Gen Tox En 2010; 696: 101–106.
- 46Robert D B. An up-and-down procedure for acute toxicity testing. Fundam Appl Toxicol 1985; 5: 151–157.
- 47Chanter DO, Heywood R. The LD50 test: Some considerations of precision. Toxicol Lett 1982; 10: 303–307.
- 48Sevcik C. LD50 determination: Objections to the method of Beccari as modified by Molinengo. Toxicon 1987; 25: 779–783.
- 49Wang W, Deng L, Xu S, Zhao X, Lv N, Zhang G, Gu N, Hu R, Zhang J, Liu J and others. A reconstituted “two into one” thermosensitive hydrogel system assembled by drug-loaded amphiphilic copolymer nanoparticles for the local delivery of paclitaxel. J Mater Chem B 2013; 1: 552–563.